Parathyroid disorder, NOS: Difference between revisions
Ttenbergen (talk | contribs) m Text replacement - "Hyperphosphatemia, hypophosphotemia or other disorder of phosphate metabolism" to "Hypophosphatemia" |
|||
(8 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle = | | OldDxArticle = | ||
| CurrentStatus = | | CurrentStatus = reconciled | ||
| InitialEditorAssigned = Gail Hall | | InitialEditorAssigned = Gail Hall | ||
}} | }} | ||
Line 16: | Line 16: | ||
== Alternate ICD10s to consider coding instead or in addition == | == Alternate ICD10s to consider coding instead or in addition == | ||
*[[Parathyroid gland, benign neoplasm]] | *[[Parathyroid gland, benign neoplasm]] | ||
*[[ | *[[Parathyroid gland, primary malignancy]] | ||
*[[Vitamin D deficiency]] | *[[Vitamin D deficiency]] | ||
*[[Endocrine gland NOS, primary malignancy]] | *[[Endocrine gland NOS, primary malignancy]] | ||
Line 25: | Line 25: | ||
*[[Hypocalcemia]] | *[[Hypocalcemia]] | ||
*[[Hypercalcemia]] | *[[Hypercalcemia]] | ||
*[[ | *[[Hypophosphatemia]] | ||
*[[Multiple endocrine adenomatosis (multiple endocrine neoplasia syndrome, MEN)]] | *[[Multiple endocrine adenomatosis (multiple endocrine neoplasia syndrome, MEN)]] | ||
*[[Osteoporosis without new pathologic fracture]] | *[[Osteoporosis without new pathologic fracture]] | ||
Line 33: | Line 33: | ||
== Related CCI Codes == | == Related CCI Codes == | ||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} |